Navigation Links
Medarex in Medical News

PharmAthene and Medarex Announce Additional $0.8 Million U.S. Government Appropriation for Continued Development of Anthrax Therapeutic Valortim(TM)

ANNAPOLIS, Md. and PRINCETON, N.J., Nov. 6 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, and Medarex, Inc. (Nasdaq: MEDX ), a leading monoclonal antibody company, today announced that...

Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti-PD1 Antibody

Addition of Hepatitis C Treatment to Ongoing Oncology Program for MDX-1106 PRINCETON, N.J., Oct. 29 /PRNewswire-FirstCall/ -- Ono Pharmaceutical Co., Ltd. and Medarex, Inc. (Nasdaq: MEDX ) announced today the allowance of an investigational new drug application (IND) filed with the U.S. Food &...

New Report Just Published: World Multiple Myeloma Therapeutics Market Report

...rma Services Becomes Recommended CRO for Multiple Myeloma Drug R&D II-53 Celgene Certifies McKesson Specialty to Launch Revlimid II-53 medarex and PacMab to Co-Develop Blood Cancer Therapies II-53 Gamida Cell and Teva to Co-Develop Therapy for Hematological Malignancies II-54 Glax...

Medarex Announces Clinical Data for MDX-1401 in Hodgkin's Lymphoma at Annual Meeting of the American Association for Cancer Research

...fully human, non-fucosylated antibody. About medarex medarex is a biopharmaceutical company focused on the disc...ion, autoimmune disorders and infectious diseases. medarex applies its UltiMAb(R) technology and product deve...

Medarex to Receive Milestone Payment for Approval of SIMPONI(TM) for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

.... Under the agreement with Centocor Ortho Biotech, medarex will receive future sales-based royalty payments f...opment for the treatment of cancer. About medarex medarex is a biopharmaceutical company focused on the disc...

Medarex Highlights Oncology Pipeline at Needham Cancer Therapeutics Conference in New York City

...l, Senior Vice President of Product Development at medarex presented highlights from key programs in Medarex'...available in the Investor Relations section of the medarex website at www.medarex.com . Highlights from...In addition to the highlighted oncology portfolio, medarex is developing a number of promising products outsi...

Medarex Announces 2008 Fourth Quarter and Year End Financial Results

...oximately $1.7 million related to Celldex . medarex ended 2008 with approximately $353.7 million in ca...or the three-month period ended December 31, 2008, medarex reported a net loss of $43.0 million, or ($0.33) p..., or approximately $146 million for the full year. medarex currently expects its cash burn rate for the full ...

Medarex to Announce 2008 Fourth Quarter and Year-End Financial Results on Wednesday, February 25, 2009

...ational); passcode number 263-79-360. About medarex medarex is a biopharmaceutical company focused on the disc...ion, autoimmune disorders and infectious diseases. medarex applies its UltiMAb(R) technology and product deve...

Medarex to Receive Milestone Payment from MedImmune for Allowance of an Investigational New Drug Application for MEDI-546

...er 2004, MedImmune entered into collaboration with medarex to focus on two specific antibodies, MDX-1103 (now...vities. Prior to the beginning of pivotal studies, medarex may elect to co-develop the products in return for... profits in the United States. In all other cases, medarex will be entitled to receive milestone payments and...

Medarex Reviews Recent Highlights and Outlook for 2009

...Howard H. Pien. Financial Guidance Update medarex is committed to the consistent management of resou...cross the organization. For the full year of 2008, medarex currently expects a cash burn rate per month of ap...d the net contributions to the ipilimumab program. medarex expects its monthly cash burn rate per month for t...
Medarex in Medical Technology

Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-CXCR4 Antibody, MDX-1338

...ted States will be diagnosed with AML. About medarex medarex is a biopharmaceutical company focused on the disc...ion, autoimmune disorders and infectious diseases. medarex applies its UltiMAb(R) technology, product develop...

Medarex Announces Primary Endpoint Achieved in MDX-1100 Anti-IP-10 Antibody Phase 2 Trial for Rheumatoid Arthritis

...000 Americans with ulcerative colitis. About medarex medarex is a biopharmaceutical company focused on the disc...ion, autoimmune disorders and infectious diseases. medarex applies its UltiMAb(R) technology and product deve...

Medarex Announces Preclinical Data from Multiple Research Programs Demonstrating Anti-Tumor Activity in Cancer

...eeting may be found at www.aacr.org . About medarex medarex is a biopharmaceutical company focused on the disc...ion, autoimmune disorders and infectious diseases. medarex applies its UltiMAb(R) technology and product deve...

Medarex Announces Enhanced Activity Data with Second Generation Anti-CD30 Antibody for Malignant Lymphoma

...nd initial efficacy of the antibody. About medarex medarex is a biopharmaceutical company focused on the disc...gulatory applications for marketing authorization. medarex is committed to building value by developing a div...

Medarex Announces Initiation of Phase 1b Clinical Development Program with MDX-1106 for the Treatment of Cancer

...5, Ono entered into a collaboration agreement with medarex to research and develop a fully human anti-PD-1 an...cluding with anti-CTLA-4 blockade. About medarex medarex is a biopharmaceutical company focused on the disc...

Medarex Receives Milestone Payment for Investigational Antibody Targeting Integrin Receptors

...s generated using Medarex's UltiMAb(R) technology. medarex may receive future milestone payments and royaltie...n, President and CEO of Medarex. About Medarex medarex is a biopharmaceutical company focused on the disc...gulatory applications for marketing authorization. medarex is committed to building value by developing a div...

Medarex Receives Milestone Payment from Pfizer for Investigational New Drug Application Filing

...body generated by Medarex's UltiMAb(R) technology. medarex may receive future milestone payments and royaltie...reat life-threatening diseases." About Medarex medarex is a biopharmaceutical company focused on the disc...gulatory applications for marketing authorization. medarex is committed to building value by developing a div...

Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology

...e found at http://www.esmo.org . About Medarex medarex is a biopharmaceutical company focused on the disc...gulatory applications for marketing authorization. medarex is committed to building value by developing a div...ite at http://www.medarex.com . Medarex(R), the medarex logo and UltiMAb(R) are registered trademarks of M...

Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus

... medarex to Receive Milestone Payment from MedImmune PRIN...vities. Prior to the beginning of pivotal studies, medarex may elect to co-develop the products in return for... profits in the United States. In all other cases, medarex will be entitled to receive milestone payments and...

Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-PD-L1 Antibody, MDX-1105

... cancer and infectious disease." About Medarex medarex is a biopharmaceutical company focused on the disc...gulatory applications for marketing authorization. medarex is committed to building value by developing a div..., visit its website at http://www.medarex.com . medarex Statement on Cautionary Factors Except for the h...
Medarex in Biological News

Mass Biologic Labs/UMass Med School and Medarex license C. difficile monoclonal antibody to Merck

WHITEHOUSE STATION N.J., PRINCETON, N.J. and JAMAICA PLAIN, Mass., April 21, 2009 Merck & Co., Inc., (through an affiliate), Medarex, Inc. (NASDAQ: MEDX) and Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) today announced that they have signed an...
Medarex in Biological Technology

BioWa and Medarex Announce License of BioWa's COMPLEGENT(TM) Technology

PRINCETON, N.J., July 16 /PRNewswire-FirstCall/ -- BioWa, Inc. and Medarex, Inc. (Nasdaq: MEDX ) announced today that they have entered into a license agreement which provides Medarex with the first ever access to BioWa's COMPLEGENT(TM) Technology for enhancing the complement-dependent cytoto...

Biotech Hot in July Driven by Positive Drug Data and Acquisitions

...e sponsorship and three other antibodies being co-developed with other partners, and rights to pre-clinical assets in various stages of development by medarex - in particular, monoclonal antibodies focused in oncology and immunology. It wasn't all good news for biotechs. Genzyme shares tumbled more th...

Medarex to Host Clinical Program Update Conference Call on Tuesday, June 2, 2009

...., Senior Vice President of Product Development at medarex will provide an update and recent highlights from ...nal); the replay passcode is 4826956. About medarex medarex is a biopharmaceutical company focused on the disc...

Medarex Announces 2009 First Quarter Financial Results

...2.4 million in 2008 to $10.5 million in 2009. medarex ended the first quarter of 2009 with approximately... During the first quarter, medarex received a milestone payment from its partner, Med...proval. In connection with the approval in Canada, medarex received an undisclosed milestone payment from lic...

Medarex to Host Business and Financial Update Conference Call on Thursday, April 30, 2009

...ternational); passcode number 1477334. About medarex medarex is a biopharmaceutical company focused on the dis...ion, autoimmune disorders and infectious diseases. medarex applies its UltiMAb(R) technology and product deve...

Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology

...eeting may be found at www.asco.org . About medarex medarex is a biopharmaceutical company focused on the disc...ion, autoimmune disorders and infectious diseases. medarex applies its UltiMAb(R) technology and product deve...

Medarex to Present at the Needham Cancer Therapeutics Conference

...available in the Investor Relations section of the medarex website at www.medarex.com . An archived edition ...will be available following the event. About medarex medarex is a biopharmaceutical company focused on the disc...

Medarex Announces Presentations at Annual Meeting of the American Association for Cancer Research

...eeting may be found at www.aacr.org . About medarex medarex is a biopharmaceutical company focused on the disc...ion, autoimmune disorders and infectious diseases. medarex applies its UltiMAb(R) technology and product deve...

Medarex Announces Allowance of Investigational New Drug Application for Company's First Antibody-Drug Conjugate, MDX-1203

...arex's Antibody-Drug Conjugate (ADC) Technology medarex has enhanced its core UltiMAb(R) antibody platform...o an antibody using a stable peptide-based linker. medarex believes that its ADC technology overcomes many of...ide therapeutic window with minimal toxicity. medarex has conducted multiple preclinical studies on seve...

Medarex to Present at the 27th Annual J.P. Morgan Healthcare Conference

...available in the Investor Relations section of the medarex website at www.medarex.com . An archived edition ...will be available following the event. About medarex medarex is a biopharmaceutical company focused on the disc...
Other Tags
(Date:8/27/2014)... 27, 2014 Janice Holly Booth ... when no-one would join her on an adventure outing to ... extreme sport involving ropes, harnesses and rappelling into mysterious, dark ... solo travel but definitely not my last,” she says. “I ... pushed me to the edge, and experienced first-hand the kind ...
(Date:8/27/2014)... 2014 The Connecticut Community for Addiction Recovery ... 19, 2014, from 10:00 AM – 2:00 PM in Bushnell ... from participants across the state to show their support for ... Connecticut’s state capitol. , Recovery Walks! is a celebration for ... alcohol and other drugs as well as their families, friends, ...
(Date:8/26/2014)... (PRWEB) August 27, 2014 Hearing aids ... can be hard for plan holders to determine what their ... now participating in several additional health plans and has published ... financial assistance page . , The following is a ... is a participating provider: , NYSHIP/ NYS Empire Plan - ...
(Date:8/26/2014)... 27, 2014 Emerging and established leaders ... useful to those they serve – which includes their ... at http://www.PerWickstrom.com and read his latest must-read ... Maintain their Edge.” , “Leadership is not ... can therefore be assumed,” commented Per Wickstrom, who blogs ...
(Date:8/26/2014)... August 27, 2014 There are a ... however the reality is cruel. Some people, especially ladies ... may not save enough money to be affluent. Today, ... delighted to announce its new catalog, Flash Deals (also ... bags, outdoor accessories and more from this company are ...
Breaking Medicine News(10 mins):Health News:Best-selling Author Janice Holly Booth Offers Tips to Navigating Fear and Living a Fuller Life 2Health News:The CT Community for Addiction Recovery to Proudly Host 15th Annual Recovery Walks! 2Health News:East End Hearing of Long Island Now Participating in Many Local Health Plans 2Health News:East End Hearing of Long Island Now Participating in Many Local Health Plans 3Health News:Per Wickstrom’s Latest Blog Post Provides 10 Tips to Help Leaders Maintain their Edge 2Health News:Become a Rich Person Right Away By Taking Advantage Of Fecbek.com's Flash Deals 2
(Date:8/26/2014)... mathematical sciences at New Jersey Institute of Technology (NJIT), ... clock that sets the pace for daily life. , ... other mammals with fundamental rhythms of life that include ... and with seasonal change. The brain,s circadian clock controls ... which, when disrupted by experiences such as jet lag ...
(Date:8/26/2014)... combining plasmonics and optical microresonators, researchers at the ... new optical amplifier (or laser) design, paving the ... made optical systems at the microscopic scale that ... J. Gary Eden, a professor of electrical and ... amplifiers are well-suited for routing optical power on ...
(Date:8/26/2014)... the University of Liverpool has recommended investing in dog owner ... and problems such as obesity in both people and their ... 1990, the researchers found that access to dog-friendly walking environments ... people to get out and take more exercise with their ... don,t take their dogs for a walk. In the UK, ...
Breaking Biology News(10 mins):Researching fundamental rhythms of life 2Researching fundamental rhythms of life 3Symphony of nanoplasmonic and optical resonators produces laser-like light emission 2Education and dog-friendly neighbourhoods could tackle obesity 2
Other Contents